• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

K11.1、Na1.5 和 Ca1.2 转运蛋白作为药物心脏毒性的抗靶标。

K11.1, Na1.5, and Ca1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity.

机构信息

Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.

Faculty of Chemistry, Nicolaus Copernicus University, 87-100 Toruń, Poland.

出版信息

Int J Mol Sci. 2020 Oct 30;21(21):8099. doi: 10.3390/ijms21218099.

DOI:10.3390/ijms21218099
PMID:33143033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7663169/
Abstract

Safety assessment of pharmaceuticals is a rapidly developing area of pharmacy and medicine. The new advanced guidelines for testing the toxicity of compounds require specialized tools that provide information on the tested drug in a quick and reliable way. Ion channels represent the third-largest target. As mentioned in the literature, ion channels are an indispensable part of the heart's work. In this paper the most important information concerning the guidelines for cardiotoxicity testing and the way the tests are conducted has been collected. Attention has been focused on the role of selected ion channels in this process.

摘要

药品安全性评估是药学和医学中一个快速发展的领域。新的化合物毒性测试高级指南需要专门的工具,这些工具能够快速可靠地提供有关测试药物的信息。离子通道代表着第三大目标。正如文献中提到的,离子通道是心脏工作不可或缺的一部分。本文收集了有关心脏毒性测试指南和测试方法的最重要信息。重点关注了在这个过程中选定的离子通道的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fedc/7663169/c4a6de36052d/ijms-21-08099-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fedc/7663169/6e3e30046e0c/ijms-21-08099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fedc/7663169/02c960970639/ijms-21-08099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fedc/7663169/c4a6de36052d/ijms-21-08099-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fedc/7663169/6e3e30046e0c/ijms-21-08099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fedc/7663169/02c960970639/ijms-21-08099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fedc/7663169/c4a6de36052d/ijms-21-08099-g003.jpg

相似文献

1
K11.1, Na1.5, and Ca1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity.K11.1、Na1.5 和 Ca1.2 转运蛋白作为药物心脏毒性的抗靶标。
Int J Mol Sci. 2020 Oct 30;21(21):8099. doi: 10.3390/ijms21218099.
2
Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity.电压门控离子通道阻滞是BIMU8诱导心脏毒性的潜在机制。
Toxicol Lett. 2017 Aug 5;277:64-68. doi: 10.1016/j.toxlet.2017.05.024. Epub 2017 May 25.
3
CardioDPi: An explainable deep-learning model for identifying cardiotoxic chemicals targeting hERG, Cav1.2, and Nav1.5 channels.CardioDPi:一种用于识别靶向 hERG、Cav1.2 和 Nav1.5 通道的心脏毒性化学物质的可解释深度学习模型。
J Hazard Mater. 2024 Aug 5;474:134724. doi: 10.1016/j.jhazmat.2024.134724. Epub 2024 May 24.
4
Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels.心率过缓药物伊伐布雷定对人体心脏离子通道的药理学特性
Cell Physiol Biochem. 2019;53(1):36-48. doi: 10.33594/000000119.
5
Antiepileptic Drug Tiagabine Does Not Directly Target Key Cardiac Ion Channels Kv11.1, Nav1.5 and Cav1.2.抗癫痫药物噻加宾并不直接作用于关键心脏离子通道Kv11.1、Nav1.5和Cav1.2。
Molecules. 2021 Jun 9;26(12):3522. doi: 10.3390/molecules26123522.
6
Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.抗惊厥药物瑞替加滨对心脏电特性的调节作用。
Toxicol Appl Pharmacol. 2017 Aug 15;329:309-317. doi: 10.1016/j.taap.2017.06.018. Epub 2017 Jun 20.
7
Semisupervised Learning to Boost hERG, Nav1.5, and Cav1.2 Cardiac Ion Channel Toxicity Prediction by Mining a Large Unlabeled Small Molecule Data Set.半监督学习通过挖掘大型未标记小分子数据集来提高 hERG、Nav1.5 和 Cav1.2 心脏离子通道毒性预测。
J Chem Inf Model. 2024 Aug 26;64(16):6410-6420. doi: 10.1021/acs.jcim.4c01102. Epub 2024 Aug 7.
8
Regulatory effects of non-steroidal anti-inflammatory drugs on cardiac ion channels Nav1.5 and Kv11.1.非甾体抗炎药对心脏离子通道 Nav1.5 和 Kv11.1 的调节作用。
Chem Biol Interact. 2021 Apr 1;338:109425. doi: 10.1016/j.cbi.2021.109425. Epub 2021 Feb 19.
9
MultiCBlo: Enhancing predictions of compound-induced inhibition of cardiac ion channels with advanced multimodal learning.MultiCBlo:利用先进的多模态学习增强化合物诱导的心脏离子通道抑制预测。
Int J Biol Macromol. 2024 Sep;276(Pt 2):133825. doi: 10.1016/j.ijbiomac.2024.133825. Epub 2024 Jul 11.
10
Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic.常见止泻药物洛哌丁胺的促心律失常机制:阿片类药物滥用流行带来的启示
Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1133-7. doi: 10.1007/s00210-016-1286-7. Epub 2016 Aug 16.

引用本文的文献

1
CardioGenAI: a machine learning-based framework for re-engineering drugs for reduced hERG liability.CardioGenAI:一种基于机器学习的框架,用于重新设计药物以降低hERG风险。
J Cheminform. 2025 Mar 5;17(1):30. doi: 10.1186/s13321-025-00976-8.
2
Citalopram & escitalopram: Mechanisms of cardiotoxicity, toxicology predisposition and risks of use in geriatric & hemodialysis populations.西酞普兰与艾司西酞普兰:心脏毒性机制、毒理学易感性以及在老年和血液透析人群中的使用风险
Glob Cardiol Sci Pract. 2024 Aug 1;2024(4):e202434. doi: 10.21542/gcsp.2024.34.
3
An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil.

本文引用的文献

1
N-Substituted Nipecotic Acids as (S)-SNAP-5114 Analogues with Modified Lipophilic Domains.作为具有修饰亲脂性结构域的(S)-SNAP-5114类似物的N-取代哌啶酸
ChemMedChem. 2020 May 6;15(9):756-771. doi: 10.1002/cmdc.201900719. Epub 2020 Apr 7.
2
Genetic potassium channel-associated epilepsies: Clinical review of the K family.遗传性钾离子通道相关性癫痫:K 家族的临床综述。
Eur J Paediatr Neurol. 2020 Jan;24:105-116. doi: 10.1016/j.ejpn.2019.12.002. Epub 2019 Dec 14.
3
Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
一种具有口服活性的流感 A 病毒进入抑制剂可保护小鼠,并与奥司他韦和巴洛沙韦协同作用。
Sci Adv. 2024 Feb 23;10(8):eadk9004. doi: 10.1126/sciadv.adk9004.
4
Unveiling the Multifaceted Problems Associated with Dysrhythmia.揭示心律失常相关的多方面问题。
Int J Mol Sci. 2023 Dec 23;25(1):263. doi: 10.3390/ijms25010263.
5
PBIT : A robust and comprehensive tool for screening pathogenic proteomes for drug targets and prioritizing vaccine candidates.PBIT:一种强大而全面的工具,用于筛选致病性蛋白质组中的药物靶点,并对疫苗候选物进行优先级排序。
Protein Sci. 2024 Feb;33(2):e4892. doi: 10.1002/pro.4892.
6
2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.2B 已确定:血清素受体 2B 在药物发现中的未来。
J Med Chem. 2023 Aug 24;66(16):11027-11039. doi: 10.1021/acs.jmedchem.3c01178. Epub 2023 Aug 16.
7
Local Anesthetic Like Inhibition of the Cardiac Na Channel Nav1.5 by Chloroquine and Hydroxychloroquine.氯喹和羟氯喹对心脏钠通道Nav1.5的局部麻醉样抑制作用
J Exp Pharmacol. 2022 Nov 8;14:353-365. doi: 10.2147/JEP.S375349. eCollection 2022.
8
In Vitro and In Vivo Inhibition of the Phosphopantetheinyl Transferase PptT by Amidinoureas.酰胺脒类化合物对磷酸泛酰巯基乙胺转移酶 PptT 的体外和体内抑制作用。
J Med Chem. 2022 Feb 10;65(3):1996-2022. doi: 10.1021/acs.jmedchem.1c01565. Epub 2022 Jan 19.
9
Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers.激素敏感性癌症中膜甾体受体的分子特征。
Cells. 2021 Nov 3;10(11):2999. doi: 10.3390/cells10112999.
10
Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters.评估帕罗西汀与选定单胺和 γ-氨基丁酸转运体的分子相互作用。
Int J Mol Sci. 2021 Jun 11;22(12):6293. doi: 10.3390/ijms22126293.
新型小鼠 GABA 摄取抑制剂,对 mGAT3/4 具有增强的抑制活性及其对小鼠痛阈的影响。
Eur J Med Chem. 2020 Feb 15;188:111920. doi: 10.1016/j.ejmech.2019.111920. Epub 2019 Dec 29.
4
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes.2019/20 年简明药理学指南:酶。
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S297-S396. doi: 10.1111/bph.14752.
5
A conserved arginine/lysine-based motif promotes ER export of KCNE1 and KCNE2 to regulate KCNQ1 channel activity.一个保守的精氨酸/赖氨酸基序促进 KCNE1 和 KCNE2 的 ER 输出,以调节 KCNQ1 通道活性。
Channels (Austin). 2019 Dec;13(1):483-497. doi: 10.1080/19336950.2019.1685626.
6
A Kinetic Map of the Homomeric Voltage-Gated Potassium Channel (Kv) Family.同源性电压门控钾通道(Kv)家族的动力学图谱。
Front Cell Neurosci. 2019 Aug 20;13:358. doi: 10.3389/fncel.2019.00358. eCollection 2019.
7
Generation and propagation of the action potential.动作电位的产生与传导。
Handb Clin Neurol. 2019;160:3-22. doi: 10.1016/B978-0-444-64032-1.00001-1.
8
Computational determination of hERG-related cardiotoxicity of drug candidates.计算预测候选药物的 hERG 相关心脏毒性。
BMC Bioinformatics. 2019 May 29;20(Suppl 10):250. doi: 10.1186/s12859-019-2814-5.
9
Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol.含防腐剂氯丁醇的静脉药物制剂致尖端扭转型室性心动过速报告概述。
Drug Saf. 2019 Jul;42(7):907-913. doi: 10.1007/s40264-019-00804-7.
10
Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.评价潜在致心律失常作用:多非利特、西沙必利、索他洛尔、特非那定和维拉帕米对 hERG 和内源性 IKr 电流以及心脏动作电位的影响比较。
Toxicol Sci. 2019 Apr 1;168(2):365-380. doi: 10.1093/toxsci/kfy299.